_version_ 1866908859170291712
author Garrucho, Lidia
Joshi, Smriti
Kushibar, Kaisar
Osuala, Richard
Bobowicz, Maciej
Bargalló, Xavier
Jaruševičius, Paulius
Geissler, Kai
Schäfer, Raphael
Alberb, Muhammad
Xu, Tony
Martel, Anne
Sleiman, Daniel
Awasthi, Navchetan
Awwad, Hadeel
Vilanova, Joan C.
Martí, Robert
Schouten, Daan
Lee, Jeong Hoon
Rusu, Mirabela
Poeta, Eleonora
Vargas, Luisa
Pastor, Eliana
Zuluaga, Maria A.
Kächele, Jessica
Bounias, Dimitrios
Ertl, Alexandra
Gwoździewicz, Katarzyna
Cosaka, Maria-Laura
Abo-Elhoda, Pasant M.
Tantawy, Sara W.
Sakrana, Shorouq S.
Shawky-Abdelfatah, Norhan O.
Abdo-Salem, Amr Muhammad
Kozana, Androniki
Divjak, Eugen
Ivanac, Gordana
Nikiforaki, Katerina
Klontzas, Michail E.
García-Dosdá, Rosa
Gulsun-Akpinar, Meltem
Lafcı, Oğuz
Martín-Isla, Carlos
Díaz, Oliver
Igual, Laura
Lekadir, Karim
author_facet Garrucho, Lidia
Joshi, Smriti
Kushibar, Kaisar
Osuala, Richard
Bobowicz, Maciej
Bargalló, Xavier
Jaruševičius, Paulius
Geissler, Kai
Schäfer, Raphael
Alberb, Muhammad
Xu, Tony
Martel, Anne
Sleiman, Daniel
Awasthi, Navchetan
Awwad, Hadeel
Vilanova, Joan C.
Martí, Robert
Schouten, Daan
Lee, Jeong Hoon
Rusu, Mirabela
Poeta, Eleonora
Vargas, Luisa
Pastor, Eliana
Zuluaga, Maria A.
Kächele, Jessica
Bounias, Dimitrios
Ertl, Alexandra
Gwoździewicz, Katarzyna
Cosaka, Maria-Laura
Abo-Elhoda, Pasant M.
Tantawy, Sara W.
Sakrana, Shorouq S.
Shawky-Abdelfatah, Norhan O.
Abdo-Salem, Amr Muhammad
Kozana, Androniki
Divjak, Eugen
Ivanac, Gordana
Nikiforaki, Katerina
Klontzas, Michail E.
García-Dosdá, Rosa
Gulsun-Akpinar, Meltem
Lafcı, Oğuz
Martín-Isla, Carlos
Díaz, Oliver
Igual, Laura
Lekadir, Karim
contents Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characterization and treatment monitoring, particularly in patients receiving neoadjuvant chemotherapy. However, existing artificial intelligence models for breast magnetic resonance imaging are often developed using single-center data and evaluated using aggregate performance metrics, limiting their generalizability and obscuring potential performance disparities across demographic subgroups. The MAMA-MIA Challenge was designed to address these limitations by introducing a large-scale benchmark that jointly evaluates primary tumor segmentation and prediction of pathologic complete response using pre-treatment magnetic resonance imaging only. The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers to assess cross-continental and cross-institutional generalization. A unified scoring framework combined predictive performance with subgroup consistency across age, menopausal status, and breast density. Twenty-six international teams participated in the final evaluation phase. Results demonstrate substantial performance variability under external testing and reveal trade-offs between overall accuracy and subgroup fairness. The challenge provides standardized datasets, evaluation protocols, and public resources to promote the development of robust and equitable artificial intelligence systems for breast cancer imaging.
format Preprint
id arxiv_https___arxiv_org_abs_2603_01250
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction
Garrucho, Lidia
Joshi, Smriti
Kushibar, Kaisar
Osuala, Richard
Bobowicz, Maciej
Bargalló, Xavier
Jaruševičius, Paulius
Geissler, Kai
Schäfer, Raphael
Alberb, Muhammad
Xu, Tony
Martel, Anne
Sleiman, Daniel
Awasthi, Navchetan
Awwad, Hadeel
Vilanova, Joan C.
Martí, Robert
Schouten, Daan
Lee, Jeong Hoon
Rusu, Mirabela
Poeta, Eleonora
Vargas, Luisa
Pastor, Eliana
Zuluaga, Maria A.
Kächele, Jessica
Bounias, Dimitrios
Ertl, Alexandra
Gwoździewicz, Katarzyna
Cosaka, Maria-Laura
Abo-Elhoda, Pasant M.
Tantawy, Sara W.
Sakrana, Shorouq S.
Shawky-Abdelfatah, Norhan O.
Abdo-Salem, Amr Muhammad
Kozana, Androniki
Divjak, Eugen
Ivanac, Gordana
Nikiforaki, Katerina
Klontzas, Michail E.
García-Dosdá, Rosa
Gulsun-Akpinar, Meltem
Lafcı, Oğuz
Martín-Isla, Carlos
Díaz, Oliver
Igual, Laura
Lekadir, Karim
Computer Vision and Pattern Recognition
Artificial Intelligence
Breast cancer is the most frequently diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Dynamic contrast-enhanced magnetic resonance imaging plays a central role in tumor characterization and treatment monitoring, particularly in patients receiving neoadjuvant chemotherapy. However, existing artificial intelligence models for breast magnetic resonance imaging are often developed using single-center data and evaluated using aggregate performance metrics, limiting their generalizability and obscuring potential performance disparities across demographic subgroups. The MAMA-MIA Challenge was designed to address these limitations by introducing a large-scale benchmark that jointly evaluates primary tumor segmentation and prediction of pathologic complete response using pre-treatment magnetic resonance imaging only. The training cohort comprised 1,506 patients from multiple institutions in the United States, while evaluation was conducted on an external test set of 574 patients from three independent European centers to assess cross-continental and cross-institutional generalization. A unified scoring framework combined predictive performance with subgroup consistency across age, menopausal status, and breast density. Twenty-six international teams participated in the final evaluation phase. Results demonstrate substantial performance variability under external testing and reveal trade-offs between overall accuracy and subgroup fairness. The challenge provides standardized datasets, evaluation protocols, and public resources to promote the development of robust and equitable artificial intelligence systems for breast cancer imaging.
title The MAMA-MIA Challenge: Advancing Generalizability and Fairness in Breast MRI Tumor Segmentation and Treatment Response Prediction
topic Computer Vision and Pattern Recognition
Artificial Intelligence
url https://arxiv.org/abs/2603.01250